TLR4 and peripheral neuropathy: However, it was recently reported that NETs could trigger the NLRP3 inflammasome activation and IL-18 secretion release during the occurrence of oxaliplatin-induced peripheral neuropathy (OIPN) via the induction of the LPS-toll-like receptor 4 (TLR4)-JNK pathway (Lin et al., 2022).